TOPLINE:  Venous thromboembolism (VTE) occurred in 9% of patients with resectable and borderline resectable pancreatic ductal adenocarcinoma (PDAC) during perioperative therapy and was associated with worse overall survival.  METHODOLOGY: Patients with …

… . New blood test may spot pancreatic cancer earlier National Institutes of Health … pancreatic ductal adenocarcinoma earlier, when treatment is more likely to work … THBS2 improved performance, correctly distinguishing pancreatic cancer from non-cases 91.9% …

… sensitive nanoparticles to destroy pancreatic cancer cells in mice, … -cancer effects of drugs. Human pancreatic cancer cells had previously … cancer cells. Pancreatic cancer in focus “Pancreatic cancer is one of … long route” from the treatment being used in the …

… the researchers analysed pancreatic cancer tissue and identified a … harder for chemotherapy drugs and immune cells … reason pancreatic cancer has been stubbornly resistant to many treatments … pancreatic cancer, and it does not mean a periostin-blocking drug …

… will transform diagnosis and treatment in the years ahead, … accurate. AI will transform treatment, breast cancer survivor says … network, aimed at improving pancreatic cancer outcomes. It said that … every two weeks for treatment, and is receiving immunotherapy …

… on these strides in pancreatic cancer treatment across approved regimens and an … 40% of patients with pancreatic cancer. The drugs I'm going … antibody–drug conjugates for patients with pancreatic cancer also, because patients [with pancreatic cancer] …

… developed a groundbreaking triple-drug therapy that eradicated pancreatic … is typically resistant to conventional drugs. Despite the promising results … major step toward potentially transformative pancreatic cancer treatments. REFERENCE: Vasiliki Liaki, Sara …

… could meaningfully change the treatment landscape for pancreatic cancer. The panel highlights the …

… driver of tumor proliferation. Drugs developed to block this … The second is a drug already used in other … models of pancreatic cancer, the tumors completely regressed under treatment. Even … than a cure Beyond pancreatic cancer, this multi-target approach …

… with early pancreatic cancer compared with healthy volunteers. Pancreatic cancer is … before they show symptoms. Pancreatic cancer aggressively invades nearby organs  … threat' treatment plan effectively made pancreatic cancer cells shrink.  However …